BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24407741)

  • 1. Point-of-care screenings at the University of Minnesota: mechanism for civic engagement.
    Palombi LC; Bastianelli K; Stratton T
    J Am Pharm Assoc (2003); 2014; 54(1):56-62. PubMed ID: 24407741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a mobile pharmacist-conducted wellness clinic for rural Montana communities.
    Stratton TP; Williams RG; Meine KL
    J Am Pharm Assoc (2003); 2005; 45(3):390-9. PubMed ID: 15991761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organization and results of student pharmacist bone mineral density screenings in women.
    Harris AC; Doucette WR; Reist JC; Nelson KE
    J Am Pharm Assoc (2003); 2011; 51(1):100-4. PubMed ID: 21247833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of patient perception of pharmacists as care providers based on health screening encounters with student pharmacists.
    Palombi LC; Nelson L; Fierke KK; Bastianelli K
    J Am Pharm Assoc (2003); 2015; 55(6):626-633. PubMed ID: 26501850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and implementation of a pharmacist-managed university-based wellness center.
    Berdine HJ; O'Neil CK
    J Am Pharm Assoc (2003); 2007; 47(3):390-7. PubMed ID: 17510036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project.
    Dong BJ; Lopez M; Cocohoba J
    J Am Pharm Assoc (2003); 2017; 57(4):510-515.e2. PubMed ID: 28602784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. implementing Student Pharmacist- Led Health Outreach Events at Long-term Care Facilities in a Medically Underserved Community.
    Giruzzi M; Giruzzi N; Gonzalez V; McKeirnan K
    Sr Care Pharm; 2021 Aug; 36(8):387-396. PubMed ID: 34311817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-Care Testing in Community Pharmacies: Keys to Success From Pennsylvania Pharmacists.
    Steltenpohl EA; Barry BK; Coley KC; McGivney MS; Olenak JL; Berenbrok LA
    J Pharm Pract; 2018 Dec; 31(6):629-635. PubMed ID: 29034781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist Comfort and Awareness of HIV and HCV Point-of-Care Testing in Community Settings.
    Min AC; Andres JL; Grover AB; Megherea O
    Health Promot Pract; 2020 Sep; 21(5):831-837. PubMed ID: 31257939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
    Trapskin K; Johnson C; Cory P; Sorum S; Decker C
    J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of a novel HIV testing strategy in community pharmacies and retail clinics.
    Lecher SL; Shrestha RK; Botts LW; Alvarez J; Moore JH; Thomas V; Weidle PJ
    J Am Pharm Assoc (2003); 2015; 55(5):488-92. PubMed ID: 26359959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals.
    Snella KA; Canales AE; Irons BK; Sleeper-Irons RB; Villarreal MC; Levi-Derrick VE; Greene RS; Jolly JL; Nelson AA
    J Am Pharm Assoc (2003); 2006; 46(3):370-7. PubMed ID: 16739759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoption of a biometric screening service in community pharmacies: a qualitative study.
    Teeter BS; Braxton-Lloyd K; Armenakis AA; Fox BI; Westrick SC
    J Am Pharm Assoc (2003); 2014; 54(3):258-66. PubMed ID: 24816352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Market dynamics of community pharmacies in Minnesota, U.S. from 1992 through 2012.
    Schommer JC; Yusuf AA; Hadsall RS
    Res Social Adm Pharm; 2014; 10(1):217-31. PubMed ID: 23669250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovating the Model for Student Pharmacists to Increase Access to Hepatitis C Testing (Project IMPACT).
    Januszka J; Notarianni V; Devenny E; Harris E
    J Am Pharm Assoc (2003); 2023; 63(4):1217-1221. PubMed ID: 37037394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculin skin testing by pharmacists in a grocery store setting.
    Hecox N
    J Am Pharm Assoc (2003); 2008; 48(1):86-91. PubMed ID: 18192135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using health observances to promote wellness in community pharmacies.
    Ciardulli LM; Goode JV
    J Am Pharm Assoc (Wash); 2003; 43(1):61-8. PubMed ID: 12585753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol Point-of-Care Testing for Community Pharmacies: A Review of the Current Literature.
    Haggerty L; Tran D
    J Pharm Pract; 2017 Aug; 30(4):451-458. PubMed ID: 27121870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist-led biometric screenings: A retrospective chart review in a community pharmacy.
    Brown SA; Wensel TM; Smith W
    Res Social Adm Pharm; 2024 Feb; 20(2):145-148. PubMed ID: 37935608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.